市场调查报告书
商品编码
1494386
欧洲生命征象监测设备市场预测至 2030 年 - 区域分析 - 按产品和最终用户Europe Vital Signs Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Product and End User |
2022年欧洲生命征象监测设备市场价值为81.0112亿美元,预计2030年将达222.8546亿美元;预计2022年至2030年复合年增长率为13.5%。
即时通讯功能的整合推动了欧洲生命征象监测设备市场
医疗保健中远端存取的采用以及音讯和视讯技术的进步缩小了患者与获得医疗保健服务之间的差距。因此,远距医疗已获得显着普及,并为即时通讯(RTC)铺平了道路。将 RTC 功能整合到生命体征监测设备中,预计将使患者能够根据自己的舒适度与医疗保健提供者有效地联繫,以接受虚拟咨询和基本医疗服务。
公司正在开发采用即时技术的产品,以有效监测患者的生命征象。 2023 年 3 月,Vigilant Medical Solutions, LLC 宣布开发 Guardian 行动应用程式和医疗设备解决方案,当患者生命体征发生即时变化时,该解决方案将透过智慧型手机向院内麻醉师发出警报。 Guardian 与人工智慧技术相结合,可提供术后谵妄、中风、急性肾损伤和死亡的重要最新资讯。 Vigilant Medical Solutions, LLC 声称,当医生忙于在不同房间或手术室治疗多名患者时,Guardian 的设计目的是让患者轻鬆了解患者的生命征象。 2021 年 10 月,霍尼韦尔推出即时健康监测系统 (RTHMS)。 RTHMS 是一个智慧边缘到云端通讯平台,旨在对患者进行远端即时监控。这款针对护理人员的行动应用程式会在患者异常生命征像出现任何偏差时向他们发出警报。该公司还声称,使用 RTHMS 将使医院的管理任务减少 35%。在世界各地的医疗机构中采用和安装此类创新技术将使医疗保健部门受益并提高患者的健康品质。
因此,即时通讯功能的整合可能会在未来几年推动欧洲生命征象监测设备市场的发展。
欧洲生命征象监测设备市场概况
欧洲的生命征象监测设备市场进一步细分为德国、英国、法国、西班牙、义大利和欧洲其他地区。该地区的市场成长取决于慢性病发病率上升、产品推出数量增加、产品开发投资增加以及人口老化激增等因素。
根据国家统计局2023年4月公布的2021年人口普查资料,65岁及以上人口从2011年的920万增加到2021年的1100万。增加。因此,随着人口老化的加剧,英国对先进生命征象监测设备的需求正在增加。
此外,根据欧洲卫生系统和政策观察站2020年发布的资料,德国每6人就有1人肥胖,总人口中近15%患有糖尿病。因此,国内对血糖监测仪的需求量大。此外,德国有 1-2 名 15 岁以上的人报告患有慢性病。此外,与糖尿病相关的医疗保健服务在法国也得到报销。法国拥有参与研发、提供创新医疗器材技术的知名公司。 2020 年 10 月,法国公司 Zoook 开发并推出了非接触式医疗级温度计,以维持 COVID-19 大流行的规范。这些创新极大地促进了该国生命征象监测设备市场的成长。
欧洲生命征象监测设备市场收入及 2030 年预测(百万美元)
欧洲生命征象监测设备市场区隔
欧洲生命征象监测设备市场根据产品、最终用户和国家进行细分。
根据产品,欧洲生命征象监测设备市场分为脉搏血氧仪、血压监测仪、温度监测设备和血糖监测设备。到 2022 年,血糖监测设备细分市场占据最大份额。此外,脉搏血氧仪细分为手持式脉搏血氧仪、桌上型脉搏血氧仪和脉搏血氧仪配件。温度监测设备分为数位温度计、红外线温度计、水银温度计和液晶温度计。此外,依血压监测设备划分,市场分为数位血压计、类比血压计、动态血压计、水银血压计和血压仪配件。
依最终用户划分,欧洲生命征象监测设备市场分为医院和诊所、门诊护理中心、家庭医疗保健等。 2022 年,医院和诊所领域占最大份额。
根据国家/地区,欧洲生命征象监测设备市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2022 年,德国在欧洲生命征象监测设备市场占据主导地位。
Koninklijke Philip NV、Medtronic Plc、Nihon Kohden、GE HealthCare Technologies Inc、OMRON corp、Masimo Corp、Nonin Medical Inc、Contec Medical Systems Co Ltd 和 Baxter Intonational Inc 是欧洲生命征象监测设备市场的一些领先公司。
The Europe vital signs monitoring devices market was valued at US$ 8,101.12 million in 2022 and is expected to reach US$ 22,285.46 million by 2030; it is estimated to grow at a CAGR of 13.5% from 2022 to 2030.
Integration of Real-Time Communication Feature Fuels the Europe Vital Signs Monitoring Devices Market
The adoption of remote access in healthcare, and advancements in audio and video technologies have bridged the gap between patients and accessing healthcare services. Thus, telemedicine has gained noticeable popularity and has paved the way for real-time communication (RTC). The integration of the RTC feature in vital sign monitoring devices is expected to allow patients to connect with healthcare providers efficiently according to their comfort to receive virtual consultations and essential medical services.
Companies are developing products that incorporate real-time technologies to allow efficient monitoring of patients' vital signs. In March 2023, Vigilant Medical Solutions, LLC announced the development of the Guardian mobile app and medical device solution that would alert in-hospital anesthesiologists on their smartphones when there is a real-time change in patients' vitals. Guardian is incorporated with artificial intelligence technology that provides vital updates on postoperative delirium, stroke, acute kidney injury, and death. Vigilant Medical Solutions, LLC claims that Guardian is designed to provide easy access to patients' vitals when doctors are busy treating several patients in different rooms or operating rooms. In October 2021, Honeywell launched a Realtime Health Monitoring System (RTHMS). RTHMS is a smart edge-to-cloud communication platform intended for the remote and real-time monitoring of patients. This mobile app for caregivers alerts them after any deviation in a patient's abnormal vitals. The company has also claimed that using RTHMS would reduce hospital administrative tasks by 35%. Adopting and installing such innovative technologies in healthcare facilities worldwide would benefit the healthcare sector and enhance patient health quality.
Thus, the integration of real-time communication features is likely to propel the Europe vital signs monitoring devices market in the coming years.
Europe Vital Signs Monitoring Devices Market Overview
The vital signs monitoring devices market in Europe is further segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. The market growth in the region is determined by factors such as the rising incidences of chronic diseases, increasing number of product launches, growing investments for product developments, and a surge in the aging population.
According to the Census 2021 data published by the Office for National Statistics in April 2023, the population aged 65 and above rose to 11 million in 2021 from 9.2 million in 2011. The geriatric population is increasing with the upsurge in life expectancy and advancements in healthcare, which enhances the quality of life. Thus, demand for advanced vital signs monitoring devices in the UK is increasing with the growing aging population.
Furthermore, as per data published by the European Observatory on Health Systems and Policies in 2020, 1 out of 6 persons in Germany is obese, and nearly 15% of the total population is living with diabetes. Therefore, there is a vast demand for glucose monitors in the country. Moreover, 1-2 persons above age 15 in Germany report a chronic condition. Also, Healthcare services related to diabetes are also reimbursed in France. France has well-established companies involved in research and development, providing innovative medical device technologies. In October 2020, Zoook, a French company, developed and launched as a contactless medical-grade thermometer to maintain the norms of the COVID-19 pandemic. Such innovations contribute significantly to the vital signs monitoring devices market growth in the country.
Europe Vital Signs Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)
Europe Vital Signs Monitoring Devices Market Segmentation
The Europe vital signs monitoring devices market is segmented based on product, end user, and country.
Based on product, the Europe vital signs monitoring devices market is segmented into pulse oximeters, blood pressure monitors, temperature monitoring devices, and glucose monitors devices. The glucose monitors devices segment held the largest share in 2022. The glucose monitoring devices segment is further bifurcated into self glucose monitors and continuous glucose monitors. Additionally, the pulse oximeters segment is subsegmented into handheld pulse oximeters, table-top pulse oximeters, and pulse oximeter accessories. The temperature monitoring devices segment into digital thermometers, infrared thermometers, mercury filled thermometers, and liquid crystal thermometers. Further, by blood pressure monitoring devices, the market is categorized into digital blood pressure monitors, analog blood pressure monitors, ambulatory blood pressure monitors, mercury blood pressure monitors, and blood pressure instrument accessories.
By end user, the Europe vital signs monitoring devices market is segmented into hospitals & clinics, ambulatory care centers, home healthcare, and other. The hospitals & clinics segment held the largest share in 2022.
Based on country, the Europe vital signs monitoring devices market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe vital signs monitoring devices market in 2022.
Koninklijke Philip NV, Medtronic Plc, Nihon Kohden, GE HealthCare Technologies Inc, OMRON corp, Masimo Corp, Nonin Medical Inc, Contec Medical Systems Co Ltd, and Baxter Intonational Inc are some of the leading companies operating in the Europe vital signs monitoring devices market.